Neuberger Berman Group’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Sell |
6,177
-513
| -8% | -$17K | ﹤0.01% | 1881 |
|
|
2025
Q1 | $269K | Buy |
+6,690
| New | +$269K | ﹤0.01% | 1730 |
|
|
2024
Q4 | – | Sell |
-3,874
| Closed | -$205K | – | 1941 |
|
|
2024
Q3 | $205K | Sell |
3,874
-91,492
| -96% | -$4.83M | ﹤0.01% | 1782 |
|
|
2024
Q2 | $5.17M | Buy |
95,366
+17,364
| +22% | +$941K | ﹤0.01% | 902 |
|
|
2024
Q1 | $5.47M | Buy |
78,002
+16,779
| +27% | +$1.18M | ﹤0.01% | 900 |
|
|
2023
Q4 | $5.11M | Buy |
61,223
+13,729
| +29% | +$1.15M | ﹤0.01% | 908 |
|
|
2023
Q3 | $1.4M | Buy |
47,494
+2,108
| +5% | +$62.1K | ﹤0.01% | 1164 |
|
|
2023
Q2 | $1.48M | Buy |
45,386
+22,227
| +96% | +$725K | ﹤0.01% | 1149 |
|
|
2023
Q1 | $815K | Buy |
+23,159
| New | +$815K | ﹤0.01% | 1316 |
|